Plain-English translation of NCT06185296 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The DiaTRUST trial is testing an intelligent telemonitoring system designed to help people with type 2 diabetes who use insulin manage their condition more effectively. The system uses wearable devices (a glucose sensor and activity tracker), a smart insulin pen, and a smartphone app to track your health data. Hospital staff review this information and use computer algorithms to help adjust your insulin treatment and warn you about dangerous low blood sugar, especially at night.
People taking insulin for type 2 diabetes often struggle with dose adjustments and dangerous low blood sugar episodes. This trial is designed to see whether real-time monitoring and personalized computer-based recommendations can help doctors make better treatment decisions and keep patients safer.
You likely qualify if…
You likely don't qualify if…
The trial lasts three months. You will be randomly assigned to one of three groups: a group using the intelligent monitoring system with personalized recommendations, a group using basic monitoring, or a standard care group. If assigned to a monitoring group, you will wear a glucose sensor, use an activity tracker and smart insulin pen, and use a smartphone app. Hospital staff will contact you regularly (as needed for your care) to review your data and adjust your treatment. All participants will visit the trial site in North Jutland for in-person check-ups.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Denmark